1. |
Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body:experimental study and clinical applications. Br J Plast Surg, 1987, 40(2):113-141.
|
2. |
Cormack GC, Lamberty BG. A classification of fascio-cutaneous flaps according to their patterns of vascularisation. Br J Plast Surg, 1984, 37(1):80-87.
|
3. |
Dhar SC, Taylor GI. The delay phenomenon:the story unfolds. Plast Reconstr Surg, 1999, 104(7):2079-2091.
|
4. |
Morris SF, Taylor GI. The time sequence of the delay phenomenon:when is a surgical delay effective? An experimental study. Plast Reconstr Surg, 1995, 95(3):526-533.
|
5. |
Coşkunfirat OK, Oksar HS, Ozgentaş HE. Effect of the delay phenomenon in the rat single-perforator-based abdominal skin flap model. Ann Plast Surg, 2000, 45(1):42-47.
|
6. |
Gözü A, Poda M, Taşkin EI, et al. Pretreatment with octreotide modulates iNOS gene expression, mimics surgical delay, and improves flap survival. Ann Plast Surg, 2010, 65(2):245-249.
|
7. |
Findikcioglu F, Findikcioglu K, Yavuzer R, et al. Effect of preoperative subcutaneous platelet-rich plasma and fibrin glue application on skin flap survival. Aesthetic Plast Surg, 2012, 36(5):1246-1253.
|
8. |
Reel B, Guzeloglu M, Bagriyanik A, et al. The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats. J Surg Res, 2013, 182(1):176-184.
|
9. |
Somi MH, Hajipour B, Asl NA, et al. Pioglitazone attenuates ischemia/reperfusion-induced liver injury in rats. Transplant Proc, 2009, 41(10):4105-4109.
|
10. |
Huang PH, Sata M, Nishimatsu H, et al. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Biomed Pharmacother, 2008, 62(1):46-52.
|
11. |
Nagahama R, Matoba T, Nakano K, et al. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia. Arterioscler Thromb Vasc Biol, 2012, 32(10):2427-2434.
|
12. |
Miyamoto S, Minabe T, Harii K. Effect of recipient arterial blood inflow on free flap survival area. Plast Reconstr Surg, 2008, 121(2):505-513.
|
13. |
Ahmed LA, Salem HA, Attia AS, et al. Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats. Eur J Pharmacol, 2011, 663(1-3):51-58.
|
14. |
林丁盛, 郑鑫, 李志杰, 等. 水蛭素对大鼠随意型皮瓣存活的影响. 中华整形外科, 2011, 27(1):35-39.
|
15. |
Yang M, Angel MF, Pang Y, et al. Expression of inducible nitric oxide synthase in muscle flaps treated with ischemic postconditioning. Hand (N Y), 2012, 7(3):297-302.
|
16. |
Baynosa RC, Naig AL, Murphy PS, et al. The effect of hyperbaric oxygen on nitric oxide synthase activity and expression in ischemia-reperfusion injury. J Surg Res, 2013, 183(1):355-361.
|
17. |
Gribbe O, Samuelson UE, Wiklund NP. Effects of nitric oxide synthase inhibition on blood flow and survival in experimental skin flaps. J Plast Reconstr Aesthet Surg, 2007, 60(3):287-293.
|
18. |
McDonald WS, Lo TP Jr, Thurmond M, et al. Role of nitric oxide in skin flap delay. Plast Reconstr Surg, 2004, 113(3):927-931.
|
19. |
Polikandriotis JA, Mazzella LJ, Rupnow HL, et al. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. Arterioscler Thromb Vasc Biol, 2005, 25(9):1810-1816.
|
20. |
Zhuang Y, Hu S, Wu D, et al. A novel in vivo technique for observations of choke vessels in a rat skin flap model. Plast Reconstr Surg, 2012, 130(2):308-317.
|
21. |
Fang T, Lineaweaver WC, Chen MB, et al. Effects of vascular endothelial growth factor on survival of surgical flaps:a review of experimental studies. J Reconstr Microsurg, 2014, 30(1):1-13.
|
22. |
鲁晓波, 郝建伟, 王兆强. 早期反复短时缺血训练对皮瓣成活的影响及其机制研究. 中国修复重建外科杂志, 2006, 20(7):717-721.
|
23. |
王立夫, 岑瑛, 肖海涛. 重组腺病毒介导的血管内皮生长因子165基因增强大鼠横形腹直肌肌皮瓣活力的研究. 中国修复重建外科杂志, 2005, 19(8):617-621.
|
24. |
Xiao-Xiao T, Sen-Min W, Ding-Sheng L. Effects of vinpocetine on random skin flap survival in rats. J Reconstr Microsurg, 2013, 29(6):393-398.
|
25. |
Yamakawa K, Hosoi M, Koyama H, et al. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. Biochem Biophys Res Commun, 2000, 271(3):571-574.
|
26. |
Morris SF, Taylor GI. Predicting the survival of experimental skin flaps with a knowledge of the vascular architecture. Plast Reconstr Surg, 1993, 92(7):1352-1361.
|